These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 978382)

  • 1. [Influence of formulation of enteric coated tablets on the bioavailability of the drug. 5th Part: Bioavailability of Riboflavin enteric coated tablets (author's transl)].
    Delporte JP; Jaminet F
    J Pharm Belg; 1976; 31(4):341-54. PubMed ID: 978382
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of formulation of enteric coated tablets on the bioavailability of the drug. 4th Part: Influence of the enteric polymer dissolution pH on the "in vivo" absorption of aspirin from coated tablets (author's transl)].
    Delporte JP; Jaminet F
    J Pharm Belg; 1976; 31(3):263-76. PubMed ID: 8603
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bioavailability study of a preparation of enteric-coated tablets of sodium fluoride (author's transl)].
    Lorent M; Gervois JP; Sondagh J; Dodion L
    J Pharm Belg; 1979; 34(5):272-8. PubMed ID: 512829
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction of omeprazole with enteric-coated salicylate tablets.
    Nefesoglu FZ; Ayanoglu-Dülger G; Ulusoy NB; Imeryüz N
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):549-53. PubMed ID: 9799060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of formulation of enterosoluable preparations on the physiologic availability of the active principle. 1: Effect on the rate of liberation of acetylsalicylic acid from enteric tablets on absorption characteristics in vivo].
    Delporte JP; Jaminet F
    J Pharm Belg; 1975; 30(2):99-113. PubMed ID: 1206458
    [No Abstract]   [Full Text] [Related]  

  • 6. [The solubility kinetics of enteric-resistant tablets using riboflavin test tablets. 6. Pharmaceutic-technologic and analytic studies on gastric juice-resistant dosage forms].
    Thoma K; Oschmann R
    Pharmazie; 1991 May; 46(5):331-6. PubMed ID: 1896478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of formation of an hydrophilic and continuous network of starch on tablet properties. III. Investigation on mathematical determination of the best starch concentration which garantee the best level of bioavailability from tablets (author's transl)].
    Ringard J; Guyot-Hermann AM
    J Pharm Belg; 1979; 34(4):204-11. PubMed ID: 501514
    [No Abstract]   [Full Text] [Related]  

  • 8. Leaky enteric coating on ranitidine hydrochloride beads: dissolution and prediction of plasma data.
    Bendas ER; Ayres JW
    Eur J Pharm Biopharm; 2008 Aug; 69(3):977-85. PubMed ID: 18424095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative bioavailability of aspirin from buffered, enteric-coated and plain preparations.
    Latini R; Cerletti C; de Gaetano G; Dejana E; Galletti F; Urso R; Marzot M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):313-8. PubMed ID: 3733281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of dissolving pH of enteric coating agent on bioavailability of enteric coated tablets of erythromycin in man (author's transl)].
    Watanabe Y; Sano M; Motohashi K; Yoneda R
    Yakugaku Zasshi; 1978 Aug; 98(8):1092-100. PubMed ID: 30834
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of cimetidine on bioavailability of enteric-coated aspirin tablets.
    Paton TW; Walker SE; Leung FY; Little AH
    Clin Pharm; 1983; 2(2):165-6. PubMed ID: 6883946
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bioavailability of a valproic acid preparation. The relative bioavailability of enteric-resistant valproic acid preparations in tablet form with simultaneously administered tetradeuterated valproic acid as the bioavailability reference].
    Hoffmann F; Jancik BC; von Unruh GE
    Arzneimittelforschung; 1986 Jul; 36(7):1118-22. PubMed ID: 3094548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Change of relative bioavailability of riboflavin by the fluid intake (author's transl)].
    Frömming KH; Mehnert W; Vetter G
    Arzneimittelforschung; 1981; 31(12):2159-62. PubMed ID: 7199319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic profile and bioavailability of a new galenic formulation of ticlopidine.
    Desager JP; van Nieuwenhuyze Y; Dricot J; Berger Y; Harvengt C
    Int J Clin Pharmacol Res; 1990; 10(4):247-50. PubMed ID: 2079383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of food and tablet formulation on plasma prednisolone levels following administration of enteric-coated tablets.
    Lee DA; Taylor GM; Walker JG; James VH
    Br J Clin Pharmacol; 1979 May; 7(5):523-8. PubMed ID: 475947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enteric-coated pelletized aspirin. Gastrointestinal blood loss and bioavailability.
    Portek I; Graham G; Fleming A
    Med J Aust; 1981 Jul; 2(1):39-40. PubMed ID: 6974303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The bioavailability of enteric coated diclofenac formulations. 2. Bioavailability following single administration of a multiple-unit formulation in comparison to a single-unit formulation under fasting and non-fasting conditions].
    Scheidel B; Blume H; Walter K; Stanislaus F; Babej-Dölle RM
    Arzneimittelforschung; 1994 Apr; 44(4):544-50. PubMed ID: 8011009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative bioavailability and in vitro characterization of two brands of diclofenac sodium enteric-coated tablets.
    el-Sayed Y; Suleiman MS; Hasan M; Najib N; Muti H; Abdulhameed M
    Int J Clin Pharmacol Ther Toxicol; 1988 Oct; 26(10):487-91. PubMed ID: 3235214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug formulation and biologic availability.
    Poole JW
    Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biological availability of gastric juice-resistant coated diclofenac preparations. 1. Bioavailability study following a single administration of a multiple-unit formulation in comparison with a single-unit formulation].
    Scheidel B; Blume H; Walter K; von Nieciecki A; Babej-Dölle RM
    Arzneimittelforschung; 1993 Nov; 43(11):1211-5. PubMed ID: 8292067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.